Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity
- PMID: 18090039
- DOI: 10.1097/QAD.0b013e3282a4a632
Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity
Abstract
Objective: In a recent report [Haynes et al. Science 2005; 308:1906-1908], difficulties in eliciting broadly neutralizing antibodies to HIV were linked to the binding of prototypic broadly neutralizing monoclonal antibodies to autoantigens and in particular, to the binding of two antigp41 antibodies, 2F5 and 4E10, to the autoantigen cardiolipin. We used a number of assays to understand whether 2F5 and 4E10 are autoreactive, polyreactive, or have a generalized affinity for lipids that may facilitate recognition of their membrane proximal epitopes.
Methods: 2F5 and 4E10 were evaluated for autoreactivity using diagnostic assays developed to detect serum antibodies associated with antiphospholipid syndrome (APS). As an indication of polyreactivity, we measured the binding of 2F5 and 4E10 to liposomal bilayers of differing composition using surface plasmon resonance (SPR) spectroscopy and to protein microarrays using biochip technology.
Results: 2F5 showed completely negative results in the APS and SPR studies, indicating that it is neither autoreactive nor absolutely requires phospholipid binding for epitope recognition. In contrast, 4E10 bound to more than one lipid and showed weak activity in the APS studies. The activity displayed by 4E10 more closely resembles that of antiphospholipid antibodies elicited during many infections than that of autoimmune APS antibodies, at variance with the notion that difficulites in eliciting 4E10-like antibodies can be attributed to tolerance mechanisms. The microarray studies further indicated that broadly neutralizing anti-HIV mAb are not exceptionally polyreactive.
Conclusion: These results suggest that autoantigen mimicry cannot be reliably invoked as a general mechanism for HIV immune evasion.
Comment in
-
4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues.AIDS. 2008 Mar 12;22(5):649-51. doi: 10.1097/QAD.0b013e3282f51922. AIDS. 2008. PMID: 18317008 No abstract available.
Similar articles
-
Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.Chembiochem. 2009 Apr 17;10(6):1032-44. doi: 10.1002/cbic.200800609. Chembiochem. 2009. PMID: 19283693
-
The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.J Immunol. 2007 Apr 1;178(7):4424-35. doi: 10.4049/jimmunol.178.7.4424. J Immunol. 2007. PMID: 17372000 Free PMC article.
-
Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data.AIDS. 2007 Oct 18;21(16):2161-70. doi: 10.1097/QAD.0b013e328285da15. AIDS. 2007. PMID: 18090042
-
A new paradigm in molecular recognition? Specific antibody binding to membrane-inserted HIV-1 epitopes.J Mol Recognit. 2011 Jul-Aug;24(4):642-6. doi: 10.1002/jmr.1092. J Mol Recognit. 2011. PMID: 21584875 Review.
-
Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends.Expert Rev Vaccines. 2010 Jun;9(6):645-64. doi: 10.1586/erv.10.52. Expert Rev Vaccines. 2010. PMID: 20518719 Review.
Cited by
-
The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.J Virol. 2008 Sep;82(18):8986-96. doi: 10.1128/JVI.00846-08. Epub 2008 Jul 2. J Virol. 2008. PMID: 18596094 Free PMC article.
-
Polyreactive antibodies in adaptive immune responses to viruses.Cell Mol Life Sci. 2012 May;69(9):1435-45. doi: 10.1007/s00018-011-0872-6. Epub 2011 Nov 2. Cell Mol Life Sci. 2012. PMID: 22045557 Free PMC article. Review.
-
A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies.J Virol. 2009 Sep;83(17):8451-62. doi: 10.1128/JVI.00685-09. Epub 2009 Jun 10. J Virol. 2009. PMID: 19515770 Free PMC article.
-
9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.PLoS One. 2012;7(4):e35356. doi: 10.1371/journal.pone.0035356. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22530008 Free PMC article.
-
Closing the door to human immunodeficiency virus.Protein Cell. 2013 Feb;4(2):86-102. doi: 10.1007/s13238-012-2111-9. Epub 2013 Mar 12. Protein Cell. 2013. PMID: 23479426 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous